Additionally, plasma EPX levels were higher in those with ARDS compared with those at risk, which is consistent with the fact that the intensity of EPX immunostaining is increased in the lungs of patients with ARDS compared with control (53). This evidence concerns the gene EPX and acute respiratory distress syndrome.